
Biocon’s ₹4,500 Cr QIP to Cut Debt, Power New Drug Launches: CEO Mittal
Biocon Ltd has successfully raised ₹4,500 crore through a Qualified Institutional Placement (QIP), a strategic move aimed at retiring structured debt and accelerating new product launches, according to CEO and MD Siddharth Mittal. Financial Restructuring to Boost Margins The QIP proceeds will be used to repay approximately $550 million in structured obligations, stemming from Biocon’s…